Large-scale testing (Phase 3)UnknownNCT05057130
What this trial is testing
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Who this might be right for
OsteosarcomaNeoplasms, Connective TissueNeoplasms, Connective and Soft Tissue+2 more
Blokhin's Russian Cancer Research Center 50